Anika Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2011
Total Assets: $132.8M
Liabilities Breakdown FY2011
Total Liabilities: $38.1M
Asset Breakdown
Total Assets: $132.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $35.8M | 26.9% |
| Accounts Receivable | $17.3M | 13.0% |
| Inventory | $7.3M | 5.5% |
| Property, Plant & Equipment | $36.5M | 27.5% |
| Goodwill | $8.9M | 6.7% |
| Intangible Assets | $23.1M | 17.4% |
| Other Assets | $4.0M | 3.0% |
Liabilities Breakdown
Total Liabilities: $38.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.3M | 11.3% |
| Long-Term Debt | $9.6M | 25.2% |
| Other Liabilities | $24.2M | 63.5% |